TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Allergi og Øre- Nese- Hals AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,023
|
1,018
|
525 |
| Financial expenses |
3
|
3
|
0 |
| Earnings before taxes |
624
|
684
|
99 |
| Total assets |
3,575
|
3,257
|
3,405 |
| Current assets |
3,564
|
3,235
|
3,370 |
| Current liabilities |
183
|
188
|
612 |
| Equity capital |
3,393
|
3,069
|
2,793 |
| - share capital |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
94.9%
|
94.2%
|
82.0% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
61.0%
|
67.2%
|
18.9% |
| Return on assets (ROA) |
17.5%
|
21.1%
|
2.9% |
| Current ratio |
1947.5%
|
1720.7%
|
550.7% |
| Return on equity (ROE) |
18.4%
|
22.3%
|
3.5% |
| Change turnover |
57
|
526
|
-584 |
| Change turnover % |
6%
|
107%
|
-53% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.